These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 17141504

  • 1. Vaccine strategies against latent tuberculosis infection.
    Andersen P.
    Trends Microbiol; 2007 Jan; 15(1):7-13. PubMed ID: 17141504
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Advances in tuberculosis vaccine strategies.
    Skeiky YA, Sadoff JC.
    Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
    [Abstract] [Full Text] [Related]

  • 4. A review of vaccine research and development: tuberculosis.
    Girard MP, Fruth U, Kieny MP.
    Vaccine; 2005 Dec 30; 23(50):5725-31. PubMed ID: 16153751
    [Abstract] [Full Text] [Related]

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 30; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 6. [Evolution of IGRA researches].
    Ariga H, Harada N.
    Kekkaku; 2008 Sep 30; 83(9):641-52. PubMed ID: 18979999
    [Abstract] [Full Text] [Related]

  • 7. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB, Kalra M, Verma I, Khuller GK.
    Clin Immunol; 2007 Mar 30; 122(3):239-51. PubMed ID: 17208519
    [Abstract] [Full Text] [Related]

  • 8. DNA vaccines for therapy of tuberculosis: where are we now?
    Lowrie DB.
    Vaccine; 2006 Mar 15; 24(12):1983-9. PubMed ID: 16316711
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli.
    Brun P, Zumbo A, Castagliuolo I, Delogu G, Manfrin F, Sali M, Fadda G, Grillot-Courvalin C, Palù G, Manganelli R.
    Vaccine; 2008 Apr 07; 26(16):1934-41. PubMed ID: 18342411
    [Abstract] [Full Text] [Related]

  • 11. The roles of latency-associated antigens in tuberculosis vaccines.
    Yousefi Avarvand A, Khademi F, Tafaghodi M, Ahmadipour Z, Moradi B, Meshkat Z.
    Indian J Tuberc; 2019 Oct 07; 66(4):487-491. PubMed ID: 31813436
    [Abstract] [Full Text] [Related]

  • 12. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL, Pan Q, Ma Y, Wang K, Sun P, Liu S, Zhang XL.
    Vaccine; 2009 Nov 12; 27(48):6712-22. PubMed ID: 19733584
    [Abstract] [Full Text] [Related]

  • 13. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin.
    Liang Y, Wu X, Zhang J, Li N, Yu Q, Yang Y, Bai X, Liu C, Shi Y, Liu Q, Zhang P, Li Z.
    Vaccine; 2008 Aug 18; 26(35):4536-40. PubMed ID: 18602439
    [Abstract] [Full Text] [Related]

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 18; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 15. Tuberculosis: vaccines in the pipeline.
    Ly LH, McMurray DN.
    Expert Rev Vaccines; 2008 Jul 18; 7(5):635-50. PubMed ID: 18564018
    [Abstract] [Full Text] [Related]

  • 16. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
    Fan X, Gao Q, Fu R.
    Microbiol Res; 2009 Jul 18; 164(4):374-82. PubMed ID: 17764918
    [Abstract] [Full Text] [Related]

  • 17. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
    Derrick SC, Perera LP, Dheenadhayalan V, Yang A, Kolibab K, Morris SL.
    Vaccine; 2008 Nov 11; 26(48):6092-8. PubMed ID: 18809446
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C, Yamada H, Shibata K, Maeda N, Yoshida S, Wajjwalku W, Ohara N, Yamada T, Kinoshita T, Yoshikai Y.
    J Infect Dis; 2008 May 01; 197(9):1263-74. PubMed ID: 18422438
    [Abstract] [Full Text] [Related]

  • 19. [Tuberculosis vaccines].
    Wiker HG, Bjune G.
    Tidsskr Nor Laegeforen; 2006 Oct 19; 126(20):2678-81. PubMed ID: 17057769
    [Abstract] [Full Text] [Related]

  • 20. Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection.
    Lin MY, Ottenhoff TH.
    Biol Chem; 2008 May 19; 389(5):497-511. PubMed ID: 18953716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.